Vestergriffith4022

nds to polycaprolactone and poly(L-lactic acid) and is compatible with the encapsulation of a hydrophobic fluorescent dye, suggesting hydrophobic bioactive agents could be encapsulated. Taken together, we demonstrate an ability to control morphology of biocompatible polymer particles produced by the widely practiced oil-in-water/solvent extraction protocol via the addition of resveratrol and a cosolvent to the oil phase. The methodology reported is straight forward, and scalable, and expected to be of utility in applications in which a deviation from the default smooth, spherical morphology is desired.Genomic profiling technologies have enabled the development of targeted therapies designed to target specific biomarkers and molecular pathways involved in the pathophysiology of tumor initiation, metastasis, and drug resistance. In recent years, clinical trials with innovative design focus on the development of novel agents based on specific patient molecular alterations or other tumor characteristics and include patients with heterogenous tumor types. Precision oncology studies with innovative design associated with novel dose-finding approaches and data analysis focusing on subgroups of patients are characteristic of master protocols. Real-world data, patient-reported outcomes, and N-of-1 trials enhance the knowledge base of evidence to deliver personalized treatment to patients. MG0103 Master protocols accelerate drug development by enabling simultaneous multiple sub-studies that match the patient's tumor molecular profile with experimental treatment arms. However, the increased flexibility of precision oncology trials is often associated with small subpopulations of patients, which may be underpowered to draw statistically robust conclusions. Despite their limitations, innovative clinical trials continue to rapidly translate the emerging discoveries of novel drugs into unprecedented clinical outcomes in patients with cancer and to accelerate the implementation of precision oncology.Alzheimer's disease (AD) is the most prevalent form of dementia with a complex pathophysiology not fully elucidated but with limited pharmacological treatment. The Usnic acid (UA) is a lichen secondary metabolite found in two enantiomeric forms (R)-(+)-UA or (S)-(-)-UA, with antioxidant and anti-inflammatory potential. Thus, given the role of neuroinflammation and oxidative injury in the AD, this study aimed to investigate experimentally the cognitive enhancing and anti-neuroinflammatory effects of UA enantiomers. First, the interactions of UA on acetylcholinesterase (AChE) was assessed by molecular docking and its inhibitory capability on AChE was assessed in vitro. In vivo trials investigated the effects of UA enantiomers in mice exposed to Aβ1-42 peptide (400 pmol/mice) intracerebroventricularly (i.c.v.). For this, mice were treated orally during 24 days with (R)-(+)-UA or (S)-(-)-UA at 25, 50, or 100 mg/kg, vehicle, or donepezil (2 mg/kg). Animals were submitted to the novel object recognized, Morris water maze, and inhibitory-avoidance task to assess the cognitive deficits. Additionally, UA antioxidant capacity and neuroinflammatory biomarkers were measured at the cortex and hippocampus from mice. Our results indicated that UA enantiomers evoked complex-receptor interaction with AChE like galantamine in silico. Also, UA enantiomers improved the learning and memory of the animals and in parallel decreased the myeloperoxidase activity and the lipid hydroperoxides (LOOH) on the cortex and hippocampus and reduced the IL-1β levels on the hippocampus. In summary, UA restored the cognitive deficits, as well as the signs of LOOH and neuroinflammation induced by Aβ1-42 administration in mice.IκB kinase α (IKKα) is a vital component of the IKK complex, which is involved in innate immune response, inflammation, cell death and proliferation. Although the functional characteristics of IKKα have been extensively studied in mammals and fish, the roles of IKKα in avian remain largely unknown. In this study, we cloned and characterized the duck IKKα (duIKKα) gene for the first time. DuIKKα encoded a protein of 757 amino acid residues and showed high sequence identities with the goose IKKα. The duIKKα was expressed in all tested tissues, and a relatively high expression of duIKKα mRNA was detected in liver and heart. Overexpression of duIKKα dramatically increased NF-κB activity and induced the expression of duck cytokines IFN-β, IL-1β, IL-6, IL-8 and RANTES in DEFs. Knockdown of duIKKα by small interfering RNA significantly decreased LPS-, poly(IC)-, poly(dAdT)-, duck enteritis virus (DEV)-, or duck Tembusu virus (DTMUV)-induced NF-κB activation. Moreover, duIKKα exhibited antiviral activity against DTMUV infection. These findings provide important insights into the roles of duIKKα in avian innate immunity.Maize, rice, and potato starches were dispersed with phytate at pH 7, 9, and 11, and were subjected to dry-heating at 130 °C for 12 h. The residual phosphorus content and structural characteristics revealed that the treatment resulted in starch phosphorylation. Further, pasting viscosity, clarity, solubility, and swelling power were analyzed to determine the physicochemical properties of the phosphorylated starch. These heat-treated starches retained phosphorus mainly in the form of monostarch monophosphate. Phosphorylation increased the peak viscosity and decreased the pasting temperature in maize and rice starches, but not in potato starch. Paste clarity, solubility, and swelling power were also increased in phosphorylated maize and rice starches. Phosphorus content, paste clarity, solubility, and swelling power were the highest at pH 7, but the maximum paste viscosity was at pH 9. These results indicate that phytate can be used for starch phosphorylation, with the reaction efficiency based on the botanical source of the starch and the reaction pH.This work reports on the valorization of Tempranillo vine shoots for the development of bio-based packaging materials. Cellulose (F3) and nanocellulose (NANO F3) were produced by the conventional method, while less purified cellulosic fractions (F2A) and nanocrystals (NANO F2A) were extracted by simplified protocols (omitting Soxhlet and alkaline treatments) to reduce production costs and environmental impact and evaluate the potential added functionalities of these less purified materials. Although most of the hemicelluloses in F2A were digested upon acid hydrolysis, a small fraction remained in NANO F2A. On the other hand, the presence of a minor xylan fraction in F3 limited the access of sulphuric acid towards the cellulose microfibrils, hindering hydrolysis and producing heterogeneous fibrillar structures in NANO F3. The obtained materials were used to produce cellulosic films, as well as blends with agar, and their performance properties were evaluated. Overall, NANO F2A films showed the best compromise between performance and sustainability and presented additional antioxidant capacity. The properties of the films could be adjusted by the incorporation of agar, improving their ductility and water permeability.Targeted drug carrier systems not only prolong the long-term circulation of drugs, but also improve their bioavailability. To obtain a pH/temperature synergistically responsive polymer carrier, temperature and pH-sensitive groups were chemically grafted onto a cassava starch backbone. Secondly, the structure of the polymer micelle carrier was characterized, and finally the drug loading performance and capacity of the drug carrier were explored. It was observed that cumulative drug release was low when the temperature and pH values met one of two conditions. Only at a high temperature and low pH (T = 38 °C, pH = 5.5, as in tumor tissue) did cumulative drug release reach its maximum value. The design of the polymer carrier described in the present study represents a novel paradigm in precision release drug carriers.In this study, the purified polysaccharide (DCP-I) was extracted from Cordyceps militaris domesticated with Pb2+. After that, the structural feature and mechanism of lead resistance of DCP-I were investigated using novel approaches. The results showed that the average molecular weight of DCP-I was 1.206 × 103 kDa and mainly consist of Rhamnose, Galactose, Glucose, Galacturonic acid and Glucuronic acid in a molar ratio of 0.13047.68740.7841.7950.48. Besides, the main chain of DCP-I was composed by →6)-Galp-(1→, →4)-Glcp-(1→ and →1,4)-Glcp-(6→, while the side chain was →1)-Rhaf-(2→ and D-Glcp-(1→, and the DCP-I contained Alacturonic acid and Glucuronic acid. In addition, the result of Congo red test showed that DCP-I did not exist triple-helical structures. SEM, EDX and XPS analyses results showed that the functional groups of DCP-I related to C, H and O (-OH, -COOH and -C=O) could combined with Pb2+effectively. The adsorption processes were described by the Pseudo-second-order kinetic model (R2 = 0.9978) and Langmuir isotherm (R2 = 0.9979) for Pb2+ indicating that adsorption process of DCP-I to Pb2+ was a kind of single molecular layer chemical adsorption.Films made from neat chitosan and chitosan with magnetic nanoparticles (MNPs) were tested as adsorbents of arsenate ions. Sorption equilibrium and sorption kinetics studies are reported, including different models applied to enlighten experimental observations and predict results. The sorption of As (V) was reasonably explained using Freundlich isotherm for neat chitosan film although it was better represented by Langmuir equation for the composite sample. The experimental kinetics results showed that the adsorption of arsenate ions is very fast during the first minutes and then the composite seems to reach saturation, while a slow desorption in the chitosan film was observed and acceptably fitted with a pseudo first order reversible model. The adsorbent containing MNPs presented higher adsorption capacity, which was associated to the additional adsorbent capacity provided by the MNPs and its much more irregular surface area that leads to an enhanced adsorption surface. For instance, at 10 mg/L equilibrium concentration, which corresponds to an initial concentration of As (V) much higher than the normal concentration of arsenate in natural water, chitosan-MNP sample exhibits a removal capacity of 10.4 mg/g that is more than six times higher than the 1.6 mg/g shown by the chitosan film.Many native plant biopolymers or derivatives thereof have interesting biological effects and therefore the search for additional biological activities is important to map their overall effects. A low molecular weight (Mw = 7600 g/mol) hemicellulose polymer α-L-arabino(4-O-methyl-α-D-glucurono)-β-D-xylan (AGX) was isolated from the crushed roots of the Rudbeckia fulgida medicinal plant by alkaline extractions and anion-exchange chromatography. Analysis of neutral sugars revealed a predominance of xylose (82.3 wt%) and arabinose (6.8 wt%), while other neutral sugars were found only in small amounts as contaminants. The uronic acid content in Rudbeckia AGX was determined to be 8.8 wt%. Pharmacological tests showed that Rudbeckia AGX effectively suppressed cough and the initial amplitude of histamine/methacholine-induced bronchoconstriction in healthy OVA-sensitive guinea pigs. In addition, its effect at a dose of 100 mg/kg was similar to or greater than that of the positive control bronchodilator salbutamol and the antitussive codeine agent.